 | ||||
Author(s): | A. Fiechter, T. Beppu, V.S. Bisaria, A.L. Demain, A. Fang, T.K. Ghose, J. Hollo, U.P. Kralovanszky, H. Kumagai,M. Roehr | |||
Collection: | Advances in Biochemical Engineering Biotechnology v. 1 | |||
Publisher: | SPRINGER | |||
Year: | 2000 | |||
Language: | English | |||
Pages: | 207 pages | |||
Size: | 1.56 MB | |||
Extension: | ||||
[tab]
[content title="Description"]History of Modern Biotechnology, devided into two volumes (69 and 70), is devoted to the developments in different countries. A.L. Demain, A. Fang: The Natural Functions of Secondary Metabolites.- T. Beppu: Development of Applied Microbiology to Modern Biotechnology in Japan.- H. Kumagai: Microbial Production of Amino Acids in Japan.- T.K. Ghose, V.S. Bisaria: Development of Biotechnology in India.- M. Roehr: History of Biotechnology in Austria.- J. Hollo, U.P. Kralovánszky: Biotechnology in Hungary.- A. Fiechter: Biotechnology in Switzerland and a Glance at Germany.
[/content]
[content title="Content"] [/content]
[content title="About the author"]Arnold L. Demain (April 26, 1927 – April 3, 2020) was an American microbiologist.[1][2] During a 60-year career, he gained a reputation in the field of industrial microbiology. He was the Professor of Industrial Microbiology in the Biology Department at MIT and Founder and Head of Department of Fermentation Microbiology at Merck & Co. The August 2010 edition of The Journal of Antibiotics celebrated his scientific career.[3] Demain was described as "one of the world's leading industrial microbiologists" and as "a scientist constantly in the forefront of industrial microbiology and biotechnology." He was "a pioneer in research on the elucidation and regulation of the biosynthetic pathways leading to the penicillins and cephalosporins" and "instrumental in the development of the beta-lactam industry". One feature of Demain's work, according to Microbiology Australia, was his "ability to undertake fundamental research on systems with clear industrial applications, recognising that biodiscovery is the start of the road that includes strain improvement to achieve levels of product synthesis that warrant further investment to take products into the marketplace."[4][5]
Demain published over 500 papers, co-edited or co-authored fourteen books, and took out 21 U.S. patents. [/content]
[/tab]
[facebook src="bibliosciencesorg"/]
Key-Words: Télécharger History of Modern Biotechnology I EBOOK PDF EPUB DJVU. Download History of Modern Biotechnology I EBOOK PDF EPUB DJVU.
